PCVX
Vaxcyte, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -8.3% ·
share flow +8.1% ·
net new positions -9.1%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | +1 | 85.77M | $4.99B | +6 | −4 |
| Q1 2026 | 115 | +4 | 93.55M | $5.43B | +8 | −5 |
| Q4 2025 | 111 | 0 | 92.90M | $4.29B | +2 | −1 |
| Q3 2025 | 18 | +2 | 60.74M | $2.19B | +3 | −2 |
| Q2 2025 | 14 | 0 | 57.50M | $1.87B | +1 | −1 |
| Q1 2025 | 11 | -1 | 19.96M | $753.77M | — | −1 |
| Q4 2024 | 12 | +1 | 18.46M | $1.51B | +1 | — |
| Q3 2024 | 10 | +2 | 13.93M | $1.59B | +3 | −1 |
| Q2 2024 | 8 | — | 11.72M | $885.19M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 6.42M | +44.4% | $242.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (passive) | 4.41M | -2.9% | $166.43M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 3.54M | -10.7% | $133.75M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 3.54M | -10.7% | $133.75M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 2.87M | +2.4% | $108.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 2.87M | +2.4% | $108.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Norges Bank ✦ (passive) | 899.84K | -18.2% | $33.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 867.89K | +11.9% | $32.77M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Millennium Management ✦ | 413.43K | +49.5% | $15.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 245.32K | -2.3% | $9.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 196.28K | +263.0% | $7.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 96.39K | -32.0% | $3.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 6.57K | -73.2% | $248,158 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Duquesne Family Office | $7.06M | was 0.2% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 53.30K shares, $3,097 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.